This article was originally published in The Gray Sheet
Executive SummaryReceives 510(k) clearance July 29 to market the Primus hollow fiber dialyzer, "after two years of lengthy review time," the Minneapolis-based manufacturer announces Aug. 8. The dialyzer "can be reprocessed with Minntech's Renatron dialyzer reprocessing system and renalin sterilant"; it is the first dialyzer to be labeled for multiple use. Marketing will begin immediately, and shipments should begin in early September, the company says
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.